Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.33 Mn | 643.20 Mn | 93.47 Mn | 27.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.82% |
| Mar 31, 2026 | -38.25% |
| Dec 31, 2025 | -541.91% |
| Sep 30, 2025 | -8.74% |
| Jun 30, 2025 | 57.57% |
| Mar 31, 2025 | 46.60% |
| Dec 31, 2024 | -43.98% |
| Sep 30, 2024 | -109.36% |
| Jun 30, 2024 | -154.23% |
| Mar 31, 2024 | 55.39% |
| Dec 31, 2023 | -103.79% |
| Sep 30, 2023 | -78.79% |
| Jun 30, 2023 | -269.69% |
| Mar 31, 2023 | 10.12% |
| Dec 31, 2022 | 68.54% |
| Sep 30, 2022 | 6.43% |
| Jun 30, 2022 | 5.42% |
| Mar 31, 2022 | 15.10% |
| Dec 31, 2021 | -10.76% |
| Sep 30, 2021 | 33.60% |